The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 19:331-334, August 2007
doi: 10.1176/appi.neuropsych.19.3.331
© 2007 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Yulug, B.
* Articles by Kilic, E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Yulug, B.
* Articles by Kilic, E.
Related Collections
* Opioids

Clinical and Research Reports

Buprenorphine Does Not Aggrevate Ischemic Neuronal Injury in Experimental Focal Cerebral Ischemia

Burak Yulug, M.D., Ertugrul Cam, M.D., Aysegul Yildiz, M.D. and Ertugrul Kilic, M.D.

Received May 5, 2006; revised September 20, 2006; accepted September 26, 2006. Dr. Yulug is affiliated with the Department of Neurology, University of Uludag, Bursa, Turkey. Dr. Cam is affiliated with the Department of Anatomy, University of Zurich, Switzerland. Dr. Yildiz is affiliated with the Department of Psychiatry, University of Dokuz Eylul, Izmir, Turkey. Dr. Kilic is affiliated with the Department of Neurology, University of Zurich, Switzerland. Address correspondence to Dr. Yulug, University of Uludag Faculty of Medicine, Department of Neurology, Bursa 16059, Turkey; yulug{at}gmx.de (e-mail).

ABSTRACT

Buprenorphine has been increasingly used as maintenance therapy in opioid dependence as an alternative to methadone and other pharmacological therapies. However, available data suggest increased risk of cerebrovascular events in opioid-dependent patients. Therefore, an opioid that provides safety with regard to neurological function should be considered by opioid-dependent patients. The evidence for the in vitro neurotoxic effects of buprenorphine is rapidly increasing. In order to clarify whether buprenorphine is also neurotoxic under the condition of cerebral ischemia in vivo, we applied an acute dose of buprenorphine in a transient model of focal cerebral ischemia in rats. Our study provides preclinical evidence for the usage of buprenorphine during the postoperative period following ischemic events as well as for the maintenance therapy of opioid-dependent patients wherein the risk of cerebrovascular events is increased.







Get information about faster international access.

Privacy Policy

Copyright © 2007 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org